Suchergebnisse - "Brufsky, Adam"

PubPharm (23)

1

Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Rugo, H. | Liu, X. | Li, B. | +3

2

Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer : Flatiron Database Analysis

enthalten in: Clinical breast cancer | 2022

von Patt, D. | Liu, X. | Li, B. | +3

3

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

4

Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry

enthalten in: Breast cancer research and treatment | 2021

von Kaufman, P. | Hurvitz, S. | O'Shaughnessy, J. | +11

5

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

6

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

7

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

8

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice

enthalten in: Breast cancer research : BCR | 2021

von DeMichele, A. | Cristofanilli, M. | Brufsky, A. | +8

9

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice

enthalten in: Breast cancer research | 2021

von DeMichele, A. | Cristofanilli, M. | Brufsky, A. | +8

10

Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry

enthalten in: Breast cancer research and treatment | 2021

von Kaufman, P. | Hurvitz, S. | O’Shaughnessy, J. | +11